Vis enkel innførsel

dc.contributor.authorBrenne, Elisabeth
dc.contributor.authorLoge, Jon Håvard
dc.contributor.authorLie, Hanne Cathrine
dc.contributor.authorHjermstad, Marianne Jensen
dc.contributor.authorFayers, Peter
dc.contributor.authorKaasa, Stein
dc.date.accessioned2017-11-20T16:15:04Z
dc.date.available2017-11-20T16:15:04Z
dc.date.created2016-06-07T14:50:50Z
dc.date.issued2016
dc.identifier.citationPalliative Medicine : A Multiprofessional Journal. 2016, 30 (6), 587-598.nb_NO
dc.identifier.issn0269-2163
dc.identifier.urihttp://hdl.handle.net/11250/2467217
dc.description.abstractBackground: Depressive symptoms are prevalent in patients with advanced cancer, sometimes of a severity that fulfil the criteria for a major depressive episode. Aim: The aim of this study was to investigate how the item on depression in the Edmonton Symptom Assessment System with a 0–10 Numerical Rating Scale performed as a screener for major depressive episode. A possible improved performance by adding the Edmonton Symptom Assessment System-Anxiety item was also examined. Design: An international cross-sectional study including patients with incurable cancer was conducted. The Edmonton Symptom Assessment System score was compared against major depressive episode as assessed by the Patient Health Questionnaire-9. Screening performance was examined by sensitivity, specificity and the kappa coefficient. Setting: Patients with incurable cancer (n = 969), median age 63 years and from eight nationalities provided report. Median Karnofsky Performance Status was 70. Median survival was 229 days (205–255 days). Results: Patient Health Questionnaire-9 major depressive episode was present in 133 of 969 patients (13.7%). Edmonton Symptom Assessment System-Depression screening ability for Patient Health Questionnaire-9 major depressive episode was limited. Area under the receiver operating characteristic curve was 0.71 (0.66–0.76). Valid detection or exclusion of Patient Health Questionnaire-9 major depressive episode could not be concluded at any Edmonton Symptom Assessment System-Depression cut-off; by the cut-off Numerical Rating Scale ⩾ 2, sensitivity was 0.69 and specificity was 0.60. By the cut-off Numerical Rating Scale ⩾ 4, sensitivity was 0.51 and specificity was 0.82. Combined mean ratings by Edmonton Symptom Assessment System-Depression and Edmonton Symptom Assessment System-Anxiety revealed similar limited screening ability. Conclusion: The depression and anxiety items of the Edmonton Symptom Assessment System, a frequently used assessment tool in palliative care settings, seem to measure a construct other than major depressive episode as assessed by the Patient Health Questionnaire-9 instrument.nb_NO
dc.language.isoengnb_NO
dc.publisherSAGE Publicationsnb_NO
dc.titleThe Edmonton Symptom Assessment System: Poor performance as a screener for major depression in patients with incurable cancernb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionacceptedVersionnb_NO
dc.source.pagenumber587-598nb_NO
dc.source.volume30nb_NO
dc.source.journalPalliative Medicine : A Multiprofessional Journalnb_NO
dc.source.issue6nb_NO
dc.identifier.doi10.1177/0269216315620082
dc.identifier.cristin1360092
dc.description.localcode© 2016. This is the authors’ accepted and refereed manuscript to the article.nb_NO
cristin.unitcode194,65,15,0
cristin.unitnameInstitutt for klinisk og molekylær medisin
cristin.ispublishedtrue
cristin.fulltextpostprint
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel